Although rare, tumor transformation of nevi to melanoma involves the clonal expansion of cells that acquire a selective growth advantage
This shift could reflect a changing demand away from oncology toward addressing metabolic disorders. Leading the charge in the GLP1 market are five key drugs: Mounjaro, Ozempic, Wegovy, Cagrisema, and Rybelsus, which are forecast to capture 83 per cent of the GLP-1 agonist market by 2029
If more control is needed, your doctor may increase it to 14 mg once daily after at least another 30 days
Several studies have linked this diet with a reduced risk of developing eye-related conditions, including those with a genetic component like macular degeneration
GLP-1 drugs also called GLP-1 agonists were originally developed to treat type 2 diabetes
You can also take them in a range of doses